Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018 (2018), Article ID 6419805, 10 pages
https://doi.org/10.1155/2018/6419805
Research Article

Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting

1Department of Molecular Biotechnology and Health Science, Molecular Biotechnology Center, University of Torino, Torino, Italy
2Department of Translational Medicine, Istituto Interuniversitario di Miologia (IIM), University of Piemonte Orientale, Novara, Italy
3Department of Molecular Biotechnology and Health Science, Molecular Imaging Center, University of Torino, Torino, Italy
4Department of Oncology, University of Torino, Torino, Italy

Correspondence should be addressed to Chiara Riganti; ti.otinu@itnagir.araihc and Paolo Ettore Porporato; ti.otinu@otaroprop.oloap

Received 27 October 2017; Accepted 31 December 2017; Published 26 February 2018

Academic Editor: Elisabetta Ferraro

Copyright © 2018 Elisabeth Wyart et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Johns, N. A. Stephens, and K. C. H. Fearon, “Muscle wasting in cancer,” The International Journal of Biochemistry & Cell Biology, vol. 45, no. 10, pp. 2215–2229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Tisdale, “Wasting in cancer,” The Journal of Nutrition, vol. 129, pp. 243S–246S, 1999. View at Google Scholar
  3. P. E. Porporato, “Understanding cachexia as a cancer metabolism syndrome,” Oncogenesis, vol. 5, no. 2, article e200, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Fearon, F. Strasser, S. D. Anker et al., “Definition and classification of cancer cachexia: an international consensus,” The Lancet Oncology, vol. 12, no. 5, pp. 489–495, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. H. Lecker, R. T. Jagoe, A. Gilbert et al., “Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression,” The FASEB Journal, vol. 18, no. 1, pp. 39–51, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Marzetti, M. Lorenzi, F. Landi et al., “Altered mitochondrial quality control signaling in muscle of old gastric cancer patients with cachexia,” Experimental Gerontology, vol. 87, no. Part A, pp. 92–99, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Brown, M. E. Rosa-Caldwell, D. E. Lee et al., “Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice,” Journal of Cachexia, Sarcopenia and Muscle, vol. 8, no. 6, pp. 926–938, 2017. View at Publisher · View at Google Scholar
  8. G. D. Stewart, R. J. Skipworth, and K. C. Fearon, “Cancer cachexia and fatigue,” Clinical Medicine, vol. 6, no. 2, pp. 140–143, 2006. View at Publisher · View at Google Scholar
  9. J. R. Mayers, C. Wu, C. B. Clish et al., “Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development,” Nature Medicine, vol. 20, no. 10, pp. 1193–1198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Bonetto, J. E. Rupert, R. Barreto, and T. A. Zimmers, “The colon-26 carcinoma tumor-bearing mouse as a model for the study of cancer cachexia,” Journal of Visualized Experiments, vol. 117, article e54893, 2016. View at Publisher · View at Google Scholar
  11. A. A. Narsale and J. A. Carson, “Role of interleukin-6 in cachexia: therapeutic implications,” Current Opinion in Supportive and Palliative Care, vol. 8, no. 4, pp. 321–327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Reano, E. Angelino, M. Ferrara et al., “Unacylated ghrelin enhances satellite cell function and relieves the dystrophic phenotype in Duchenne muscular dystrophy mdx model,” Stem Cells, vol. 35, no. 7, pp. 1733–1746, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Geninatti-Crich, I. Szabo, D. Alberti, D. Longo, and S. Aime, “MRI of cells and mice at 1 and 7 tesla with Gd-targeting agents: when the low field is better!,” Contrast Media & Molecular Imaging, vol. 6, no. 6, pp. 421–425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Braccini, E. Ciraolo, C. C. Campa et al., “PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling,” Nature Communications, vol. 6, p. 7400, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Perino, M. Beretta, A. Kili et al., “Combined inhibition of PI3Kβ and PI3Kγ reduces fat mass by enhancing α-MSH-dependent sympathetic drive,” Science Signaling, vol. 7, no. 352, article ra110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. P. E. Porporato, N. Filigheddu, S. Reano et al., “Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice,” The Journal of Clinical Investigation, vol. 123, no. 2, pp. 611–622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Campia, C. Lussiana, G. Pescarmona, D. Ghigo, A. Bosia, and C. Riganti, “Geranylgeraniol prevents the cytotoxic effects of mevastatin in THP-1 cells, without decreasing the beneficial effects on cholesterol synthesis,” British Journal of Pharmacology, vol. 158, no. 7, pp. 1777–1786, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Wibom, L. Hagenfeldt, and U. von Dobeln, “Measurement of ATP production and respiratory chain enzyme activities in mitochondria isolated from small muscle biopsy samples,” Analytical Biochemistry, vol. 311, no. 2, pp. 139–151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Gaster, A. C. Rustan, V. Aas, and H. Beck-Nielsen, “Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes,” Diabetes, vol. 53, no. 3, pp. 542–548, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. A. Michaelis, X. Zhu, K. G. Burfeind et al., “Establishment and characterization of a novel murine model of pancreatic cancer cachexia,” Journal of Cachexia, Sarcopenia and Muscle, vol. 8, no. 5, pp. 824–838, 2017. View at Publisher · View at Google Scholar
  21. D. N. Seto, S. C. Kandarian, and R. W. Jackman, “A key role for leukemia inhibitory factor in C26 cancer cachexia,” The Journal of Biological Chemistry, vol. 290, no. 32, pp. 19976–19986, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Segatto, R. Fittipaldi, F. Pin et al., “Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival,” Nature Communications, vol. 8, no. 1, p. 1707, 2017. View at Publisher · View at Google Scholar
  23. T. Fukawa, B. C. Yan-Jiang, J. C. Min-Wen et al., “Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia,” Nature Medicine, vol. 22, no. 6, pp. 666–671, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. C. T. Hensley, B. Faubert, Q. Yuan et al., “Metabolic heterogeneity in human lung tumors,” Cell, vol. 164, no. 4, pp. 681–694, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Balietti, P. Fattoretti, B. Giorgetti et al., “A ketogenic diet increases succinic dehydrogenase activity in aging cardiomyocytes,” Annals of the New York Academy of Sciences, vol. 1171, no. 1, pp. 377–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Edalat, P. Schulte-Mecklenbeck, C. Bauer et al., “Mitochondrial succinate dehydrogenase is involved in stimulus-secretion coupling and endogenous ROS formation in murine beta cells,” Diabetologia, vol. 58, no. 7, pp. 1532–1541, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Guaras, E. Perales-Clemente, E. Calvo et al., “The CoQH2/CoQ ratio serves as a sensor of respiratory chain efficiency,” Cell Reports, vol. 15, no. 1, pp. 197–209, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. I. R. Indran, G. Tufo, S. Pervaiz, and C. Brenner, “Recent advances in apoptosis, mitochondria and drug resistance in cancer cells,” Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1807, no. 6, pp. 735–745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. K. C. Fearon, M. D. Barber, J. S. Falconer, D. C. McMillan, J. A. Ross, and T. Preston, “Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia,” World Journal of Surgery, vol. 23, no. 6, pp. 584–588, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Zhou, J. L. Wang, J. Lu et al., “Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival,” Cell, vol. 142, no. 4, pp. 531–543, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. R. J. Mailloux and M. E. Harper, “Mitochondrial proticity and ROS signaling: lessons from the uncoupling proteins,” Trends in Endocrinology and Metabolism, vol. 23, no. 9, pp. 451–458, 2012. View at Publisher · View at Google Scholar · View at Scopus